Indication intelligence, analysis and sector perception

Lower open expected; RegMed Investors’ (RMi) pre-open indications, I found Nemo

March 9, 2017 7:52am

But, I was looking for expectation

As I searched for missing positive earnings, along the way, cell therapy companies took more risks and never came to terms with investors

Anyone who reads my posts, knows that I am about making money, no matter what happens in the sector

… Dow futures are DOWN -0.13% and NASDAQ futures are DOWN -0.07%

… Companies in my trading headlights: five (5)

… Financial results: 5 - Athersys (ATHX), BioLife Solutions (BLFS), ImmunoCellular (NYSEMKT: IMUC) after close, Fibrocell (FCSC) at 8:30 am and Biostage (BSTG) at 9

… Investors need to gauge whether any advances are just speculation

Critical information ahead of “our” universe’s open! I provide intelligence and analysis for short and near-term investment.

Members only. Please login.

35 companies, 1 interpreter!

Insight, foresight and recommendation

What's Happening Today

1 hour 6 min ago
RegMed Investors (RMi) Closing Bell: a tough week; tied to cross-currents of geopolitical conflicts and recurring inflation

12 hours 49 min ago
RegMed Investors’ (RMi) pre-open: market, market and the sector pullbacks are driven by Israel retaliation against Iran tempered expectations for a rate cut

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.